Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
Ahmed K Elsayed, Manjula Nandakumar, Essam M Abdelalim, Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar
Selvaraj Vimalraj, Centre for Biotechnology, Anna University, Chennai 600025, India
Essam M Abdelalim, College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar
Author contributions: Elsayed AK, Vimalraj S and Nandakumar M wrote and reviewed the manuscript; Abdelalim EM conceptualized the idea, wrote and revised the manuscript; all authors approved the final version of the manuscript.
Supported by the Qatar National Research Fund, No. NPRP10-1221-160041.
Conflict-of-interest statement: The authors declare that they have no conflict of interest
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Essam M Abdelalim, DVM, MSc, PhD, Professor, Diabetes Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation, Al Rayyan, Doha 34110, Qatar. email@example.com
Received: November 18, 2020
Peer-review started: November 18, 2020
First decision: January 25, 2021
Revised: February 7, 2021
Accepted: March 11, 2021
Article in press: March 11, 2021
Published online: March 26, 2021